Stable dosage of levothyroxine sodium and process of production

Details Stable dosage of levothyroxine sodium and process of production Stable dosage of levothyroxine sodium and process of production

1991-11-05

1993-07-06

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Matrices

424451, 424464, 424486, 424488, A61K 918, A61K 920, A61K 948

Patent

active

052252043

ABSTRACT:
A stable dosage form of levothyroxine sodium which includes a stable complex of levothyroxine sodium and a cellulose compound, polyvinylpyrrolidone or a Poloxamer, which complex is adsorbed on the surface of a cellulose compound carrier. In a first embodiment the stable complex of levothyroxine sodium is prepared by mixing the levothyroxine sodium with a complexing agent such as polyvinylpyrrolidone or a Poloxamer, dissolving the resulting mixture in a polar organic solvent such as water, methanol, ethanol, propanol, isopropyl alcohol, methylene dichloride or butanol, adding a cellulose carrier to the liquid and subsequently drying the resulting mixture to obtain a powdery, stabilized complex of levothyroxine sodium and polyvinylpyrrolidone or Poloxamer adsorbed on the cellulose carrier. In a second embodiment the levothyroxine sodium is at least partially dissolved directly in the polar organic solvent and a cellulose carrier is added to the solution to produce the stabilized levothyroxine sodium complex. In a third embodiment the levothyroxine sodium is dry mixed with a cellulose complexing agent and a cellulose carrier to produce the stabilized levothyroxine sodium complex. The complexes can be mixed with pharmaceutically acceptable excipients for compression into tablets or placed in capsules to define stable levothyroxine sodium dosage formulations.

REFERENCES:
patent: 2889363 (1959-06-01), Ginger et al.
patent: 2889364 (1959-06-01), Ginger et al.
patent: 4344934 (1982-08-01), Martin et al.
patent: 4973469 (1990-11-01), Mulligan et al.
patent: 4999200 (1991-03-01), Casillan
patent: 5004613 (1991-04-01), Radebaugh
patent: 5008114 (1991-04-01), Lovrecich
patent: 5015479 (1991-05-01), Mulligan et al.
patent: 5064656 (1991-11-01), Gergely et al.
patent: 5066488 (1991-11-01), Merianus et al.
patent: 5066495 (1991-11-01), Moro et al.

Affiliated with

Also associated with

Rating

Stable dosage of levothyroxine sodium and process of production does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stable dosage of levothyroxine sodium and process of production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable dosage of levothyroxine sodium and process of production will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1688231